The no-observed-adverse-effect-level in drug safety...

Regulatory Toxicology and Pharmacology 2005 Vol. 42; Iss. 3

The no-observed-adverse-effect-level in drug safety evaluations: Use, issues, and definition(s)

Michael A. Dorato, Jeffery A. Engelhardt
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
42
Year:
2005
Language:
english
DOI:
10.1016/j.yrtph.2005.05.004
File:
PDF, 493 KB
english, 2005
Conversion to is in progress
Conversion to is failed